{"url_path":"/sec/mist/8-k/2026-06-15/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-15","source_url":"https://www.sec.gov/Archives/edgar/data/1408443/0001104659-26-074025-index.html","accession_number":"0001104659-26-074025","cik":"0001408443","ticker":"MIST","issuer_name":"Milestone Pharmaceuticals Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1408443/0001104659-26-074025-index.html","primary_entity_key":"0001408443","primary_entity_name":"Milestone Pharmaceuticals Inc."},"word_count":371,"has_tables":true,"body_markdown":"**Item 5.07.**\n**Submission of Matters to a Vote of Security Holders.**\n\n \n\nAt the Annual Meeting, the\nCompany’s shareholders voted on four proposals, each of which is described in more detail in the 2026 Proxy Statement. The following\nis a brief description of each matter voted upon at the Annual Meeting, as well as the final tally of the number of votes cast for, withheld\nor against each matter, and, if applicable, the number of abstentions and broker non-votes with respect to each matter.\n\n \n\n**Proposal 1.**\n**Election of Directors**\n\n \n\nThe Company’s shareholders\nelected the nominees below to the Company’s board of directors (the “**Board**”), each to hold office until the Company’s\n2027 annual meeting of shareholders (the “**2027 Annual Meeting**”), or until their successors are duly elected or appointed\nor until such directors’ earlier resignation or removal. The votes regarding the election of directors were as follows:\n\n \n\nNominee \nVotes For  \nVotes Withheld  \nBroker Non-Votes \n\nJoseph Oliveto \n 23,968,376  \n 3,390,500  \n 48,581,157 \n\nStuart M. Duty \n 24,188,870  \n 3,170,005  \n 48,581,158 \n\nSeth H.Z. Fischer \n 24,199,513  \n 3,159,363  \n 48,581,157 \n\nLisa M. Giles \n 24,212,031  \n 3,146,845  \n 48,581,157 \n\nJoseph C. Papa \n 23,437,235  \n 3,921,639  \n 48,581,159 \n\nAndrew R. Saik \n 24,111,218  \n 3,247,657  \n 48,581,158 \n\nMichael Tomsicek \n 24,205,006  \n 3,153,870  \n 48,581,157 \n\nRobert J. Wills \n 23,506,189  \n 3,852,686  \n 48,581,158 \n\n \n\n**Proposal 2.**\n**Appointment of the Auditor**\n\n \n\nProposal 2 was a proposal\nto ratify the selection by the Company’s Audit Committee of PricewaterhouseCoopers LLP as the auditor for the Company until the\nclose of the 2027 Annual Meeting and the authorization of the Board to fix the auditor’s remuneration. The votes regarding the ratification\nof the selection of the Company’s auditor were as follows:\n\n \n\nVotes For  \nVotes\nAgainst  \nAbstentions \n\n 75,025,285  \n 249,836  \n 664,912 \n\n \n\n \n\n \n\n**Proposal 3.**\n**2019 Equity Plan Amendment**\n\n \n\nProposal 3 was a proposal\nto approve the 2019 EIP, as amended, to, among other things, increase the number of ordinary shares authorized for issuance by 6,800,000\nshares. The votes regarding the 2019 EIP were as follows:\n\n \n\nVotes For  \nVotes\nAgainst  \nAbstentions  \nBroker\nNon-Votes \n\n 19,262,773  \n 5,479,043  \n 2,617,059  \n 48,581,158 \n\n \n\n**Proposal 4.**\n**Advisory Vote on Executive Compensation**\n\n \n\nProposal 4 was a proposal\nfor a non-binding advisory vote on the compensation of the Company’s named executive officers. The votes regarding the non-binding\nadvisory vote were as follows:\n\n \n\nVotes For  \nVotes\nAgainst  \nAbstentions  \nBroker\nNon-Votes \n\n 19,665,705  \n 6,990,920  \n 702,247  \n 48,581,161"}